![[Podcast] Behind the Breakthroughs: How Almac Powers Clinical Trial Success with Care](https://imgproxy.divecdn.com/5lAJkli_KcGt1FSsw4EaegjgP76IHREqYEWbhNBJOXw/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9CaW9QaGFybWFEaXZlXzEzNDZfeF83MjlfQXJ0d29yay5qcGc=.webp)
.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
AstraZeneca has tapped Korea's Alteogen to develop subcutaneous cancer drugs. Ta...
This week on "The Top Line," we explore the potential impacts of this year's siz...
AstraZeneca has shown its commitment to China amid investigations into its execu...
About three months after leaving her post as the FDA’s principal deputy commissi...
The FDA approved Tremfya as an induction therapy in adults with moderately to se...
London-listed drugmaker will establish research centre in Beijing
BB-1701 has survived Eisai’s decision not to option the HER2-directed antibody-d...
MacroGenics has made the final decision to abandon work on one of its most advan...
Endocrine-disease-focused Visen Pharmaceuticals is making its public market debu...
Orphan designation: Octreotide acetate Treatment of acromegaly, 05/08/2013 Withd...
Human medicines European public assessment report (EPAR): Mycapssa, octreotide, ...
Mandate, objectives and rules of procedure for the CVMP Pharmacovigilance Workin...
Release notes - production release version 1.7.2514-3 - 21 March 2025 - Veterina...
“With measles resurging, we cannot rely on guidelines designed for an era when t...
A lawsuit, filed by Texas and 16 other states, target a call to count gender dys...
The National Wastewater Surveillance System’s funding expires at the end of fisc...
Bill Nye critiqued HHS chief Robert F. Kennedy Jr. and his views on science and ...
At the STAT Summit on Thursday, researchers called for a "full-throated defense"...
Ozempic might feature in future US negotiations with Denmark over Greenland
DNA sequencing specialist’s decision to list in London in 2021 was seen as a vic...
Experts say there are regional disparities in medication access even as prescrip...
Paris (France), March 17, 2025 – PEP-Therapy, a clinical-stage biotechnology com...
SYDNEY, Australia, 19 March 2025: Imugene Limited (ASX:IMU), a clinical-stage im...
The FDA approved Tremfya as an induction therapy in adults with moderately to se...